182 related articles for article (PubMed ID: 23129590)
1. Protective effects of low calcium intake and low calcium absorption vitamin D receptor genotype in the California Collaborative Prostate Cancer Study.
Rowland GW; Schwartz GG; John EM; Ingles SA
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):16-24. PubMed ID: 23129590
[TBL] [Abstract][Full Text] [Related]
2. Calcium intake and prostate cancer among African Americans: effect modification by vitamin D receptor calcium absorption genotype.
Rowland GW; Schwartz GG; John EM; Ingles SA
J Bone Miner Res; 2012 Jan; 27(1):187-94. PubMed ID: 21887707
[TBL] [Abstract][Full Text] [Related]
3. Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor.
Oakley-Girvan I; Feldman D; Eccleshall TR; Gallagher RP; Wu AH; Kolonel LN; Halpern J; Balise RR; West DW; Paffenbarger RS; Whittemore AS
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1325-30. PubMed ID: 15298953
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
5. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.
Ingles SA; Ross RK; Yu MC; Irvine RA; La Pera G; Haile RW; Coetzee GA
J Natl Cancer Inst; 1997 Jan; 89(2):166-70. PubMed ID: 8998186
[TBL] [Abstract][Full Text] [Related]
6. Dietary factors and risks for prostate cancer among blacks and whites in the United States.
Hayes RB; Ziegler RG; Gridley G; Swanson C; Greenberg RS; Swanson GM; Schoenberg JB; Silverman DT; Brown LM; Pottern LM; Liff J; Schwartz AG; Fraumeni JF; Hoover RN
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):25-34. PubMed ID: 9950236
[TBL] [Abstract][Full Text] [Related]
7. Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men.
Nelson SM; Batai K; Ahaghotu C; Agurs-Collins T; Kittles RA
Nutrients; 2016 Dec; 9(1):. PubMed ID: 28036013
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
Holick CN; Stanford JL; Kwon EM; Ostrander EA; Nejentsev S; Peters U
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1990-9. PubMed ID: 17932346
[TBL] [Abstract][Full Text] [Related]
9. Dietary calcium, vitamin D, VDR genotypes and colorectal cancer.
Slattery ML; Neuhausen SL; Hoffman M; Caan B; Curtin K; Ma KN; Samowitz W
Int J Cancer; 2004 Sep; 111(5):750-6. PubMed ID: 15252846
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial.
Torkko K; Till C; Tangen CM; Goodman PJ; Song X; Schenk JM; Lucia MS; Peters U; van Bokhoven A; Thompson IM; Neuhouser ML
Cancer Prev Res (Phila); 2020 Jun; 13(6):521-530. PubMed ID: 32102946
[TBL] [Abstract][Full Text] [Related]
11. VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White men.
Torkko KC; van Bokhoven A; Mai P; Beuten J; Balic I; Byers TE; Hokanson JE; Norris JM; BarĂ³n AE; Lucia MS; Thompson IM; Leach RJ
Clin Cancer Res; 2008 May; 14(10):3223-9. PubMed ID: 18483391
[TBL] [Abstract][Full Text] [Related]
12. Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly.
Fang Y; van Meurs JB; Bergink AP; Hofman A; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
J Bone Miner Res; 2003 Sep; 18(9):1632-41. PubMed ID: 12968672
[TBL] [Abstract][Full Text] [Related]
13. Race and BMI modify associations of calcium and vitamin D intake with prostate cancer.
Batai K; Murphy AB; Ruden M; Newsome J; Shah E; Dixon MA; Jacobs ET; Hollowell CM; Ahaghotu C; Kittles RA
BMC Cancer; 2017 Jan; 17(1):64. PubMed ID: 28103838
[TBL] [Abstract][Full Text] [Related]
14. The BsmI vitamin D receptor restriction fragment length polymorphism (bb) influences the effect of calcium intake on bone mineral density.
Kiel DP; Myers RH; Cupples LA; Kong XF; Zhu XH; Ordovas J; Schaefer EJ; Felson DT; Rush D; Wilson PW; Eisman JA; Holick MF
J Bone Miner Res; 1997 Jul; 12(7):1049-57. PubMed ID: 9200004
[TBL] [Abstract][Full Text] [Related]
15. Sequence variation within the 5' regulatory regions of the vitamin D binding protein and receptor genes and prostate cancer risk.
Kidd LC; Paltoo DN; Wang S; Chen W; Akereyeni F; Isaacs W; Ahaghotu C; Kittles R
Prostate; 2005 Aug; 64(3):272-82. PubMed ID: 15717311
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor polymorphisms and prostate cancer.
Blazer DG; Umbach DM; Bostick RM; Taylor JA
Mol Carcinog; 2000 Jan; 27(1):18-23. PubMed ID: 10642433
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor FokI gene polymorphisms may be associated with colorectal cancer among African American and Hispanic participants.
Sarkissyan M; Wu Y; Chen Z; Mishra DK; Sarkissyan S; Giannikopoulos I; Vadgama JV
Cancer; 2014 May; 120(9):1387-93. PubMed ID: 24510435
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer in African-American men and polymorphism in the calcium-sensing receptor.
Schwartz GG; John EM; Rowland G; Ingles SA
Cancer Biol Ther; 2010 Jun; 9(12):994-9. PubMed ID: 20364112
[TBL] [Abstract][Full Text] [Related]
19. Interactions Between Vitamin D and Calcium Intake, Vitamin D Receptor Genetic Polymorphisms, and Colorectal Cancer Risk.
Zhang X; Fang YJ; Feng XL; Abulimiti A; Huang CY; Luo H; Zhang CX
Dig Dis Sci; 2021 Jun; 66(6):1895-1905. PubMed ID: 32627088
[TBL] [Abstract][Full Text] [Related]
20. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.
Zheng SL; Sun J; Cheng Y; Li G; Hsu FC; Zhu Y; Chang BL; Liu W; Kim JW; Turner AR; Gielzak M; Yan G; Isaacs SD; Wiley KE; Sauvageot J; Chen HS; Gurganus R; Mangold LA; Trock BJ; Gronberg H; Duggan D; Carpten JD; Partin AW; Walsh PC; Xu J; Isaacs WB
J Natl Cancer Inst; 2007 Oct; 99(20):1525-33. PubMed ID: 17925536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]